Our university is a signatory to the Uniform Biological Material Transfer Agreement (UBMTA) Master Agreement (UBMTA), a contractual mechanism published by NIH on behalf of PHS to facilitate the transfer of biological material between academic institutions. For institutions that have accepted the terms of the UBMTA master contract, it is not necessary to negotiate individual terms for any transfer of a biological material. Instead, a letter of execution is implemented, which refers to both the biological material, the supply agency and the host institution. Where possible, the Clinical/Corporate Contracts Services team will use UBMTA to expedite the transfer of applicable biological materials. 6. If you are a for-profit institution or intend to use the material for commercial purposes, please contact the License (at) helmholtz-muenchen.de The Clinical/Corporate Contracts Services team handles both incoming MTAs in which the University receives research materials from other institutions and outgoing MTAs, where we share research materials from the university with other institutions. The University of Pittsburgh requires that an outgoing MTA (or some other form of contract, for example.B. subcontracting) for university materials be sent by our university. 2. Transfers from the University of Chicago to Industry Outgoing, Corporate MTAs from the university to industry are controlled and approved by the Polsky Center.
It is not necessary to transmit this MTA through departmental, divisional or URA offices. The Polsky Centre will inform these offices about the MTA, so that a record of materials shared with the industry will be maintained. For incoming MTAs (since the owner of the research equipment determines the conditions under which he wishes to share the material with our university), the PI/PI department should provide the MTA proposed by the owner of the research equipment The TUM Patent and Licensing Office actively markets new technologies in many sectors and is responsible, on behalf of TUM, for the negotiation of contracts (confidentiality agreements, options, licensing agreements and acquisitions, etc.). Current marketing technologies can be found here. The TUM Patent and Licensing Office welcomes discussions with potentially interested parties. A material transfer contract (MTA) is a contract that governs the transfer of research material between two organizations when the recipient intends to use it for his or her own research purposes. The MTA defines the rights of the supplier and the rights and obligations of the recipient with respect to materials and all offspring, derivatives or modifications. Biological materials such as reagents, cell lines, plasmids and vectors are the most frequently transferred materials, but MTAs can also be used for other types of materials such as chemical compounds, mouse models and even certain types of software. Van den Hurk says that one of the main points of disagreement between developed and developing countries is the idea of digital information on sequencing.
Developing countries will not accept a new SMTA without an agreement to also address access to digital sequencing information, while developed countries do not want to include information on digital sequences.